While Trump's latest statements has led to significant losses for Indian pharma stocks, and investors remain cautious as they ...

In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr.

Indian benchmark indices closed little changed on Wednesday, as advances in heavyweight financial stocks offset losses in the ...

Indian benchmark indices Nifty 50 and Sensex ended the previous trade session lower. Nifty ended at 22,945.30, while Sensex ...

Indian shares edged higher Wednesday, as gains in heavyweight financials overshadowed the decline in pharma stocks triggered ...

Burgundy Private Hurun India 500 report values Reliance at Rs 17.5 lakh crore. TCS comes in second at Rs 16.1 lakh crore, and ...

Macquarie suggested a target price of Rs 7,400 for Divis Labs, Rs 1,500 for Suven Pharma, Rs 835 for Syngene and Rs 1,000 for ...

Divis Labs share price rallied 1.9% intraday, Suven Pharma share price surged 4.6%, Blue Jet Healthcare share price added 4.9 ...

Dr. Reddys Laboratories fell 5.8% to Rs 1,128.90, while Zydus Lifesciences dropped 4.8%. Sun Pharma, India's largest ...

Nifty Pharma fell as much as 3.19% on Wednesday, led by the decline in Abbott Laboratories, Lupin and Ajanta Pharma.

Stocks in the Nifty Pharma index were down by as much as 6% following US President Donald Trump's proposal to impose tariffs; ...

The decline in pharma stocks followed comments from President Donald Trump, who indicated that the US may impose tariffs of ...